208 related articles for article (PubMed ID: 11375775)
1. Parathyroid hormone: an anabolic treatment for osteoporosis.
Morley P; Whitfield JF; Willick GE
Curr Pharm Des; 2001 May; 7(8):671-87. PubMed ID: 11375775
[TBL] [Abstract][Full Text] [Related]
2. The potential of parathyroid hormone as a therapy for osteoporosis.
Rubin MR; Bilezikian JP
Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
[TBL] [Abstract][Full Text] [Related]
3. Anabolic effects of parathyroid hormone on bone.
Morley P; Whitfield JF; Willick GE
Trends Endocrinol Metab; 1997 Aug; 8(6):225-31. PubMed ID: 18406808
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone in the treatment of osteoporosis.
Fujita T
BioDrugs; 2001; 15(11):721-8. PubMed ID: 11707147
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis-treating parathyroid hormone peptides: What are they? What do they do? How might they do it?
Whitfield JF
Curr Opin Investig Drugs; 2006 Apr; 7(4):349-59. PubMed ID: 16625822
[TBL] [Abstract][Full Text] [Related]
6. The Safety and Efficacy of Parathyroid Hormone (PTH) as a Biological Response Modifier for the Enhancement of Bone Regeneration.
Tzioupis CC; Giannoudis PV
Curr Drug Saf; 2006 May; 1(2):189-203. PubMed ID: 18690930
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis.
Whitfield JF; Morley P; Willick GE
Treat Endocrinol; 2002; 1(3):175-90. PubMed ID: 15799210
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
[TBL] [Abstract][Full Text] [Related]
9. Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosis.
Miyakoshi N
Curr Pharm Des; 2004; 10(21):2615-27. PubMed ID: 15320749
[TBL] [Abstract][Full Text] [Related]
10. Developments in parathyroid hormone and related peptides as bone-formation agents.
Fox J
Curr Opin Pharmacol; 2002 Jun; 2(3):338-44. PubMed ID: 12020480
[TBL] [Abstract][Full Text] [Related]
11. The bone-building action of the parathyroid hormone: implications for the treatment of osteoporosis.
Whitfield JF; Morley P; Willick GE
Drugs Aging; 1999 Aug; 15(2):117-29. PubMed ID: 10495071
[TBL] [Abstract][Full Text] [Related]
12. Cyclization by a specific lactam increases the ability of human parathyroid hormone (hPTH)-(1-31)NH2 to stimulate bone growth in ovariectomized rats.
Whitfield JF; Morley P; Willick G; Langille R; Ross V; MacLean S; Barbier JR
J Bone Miner Res; 1997 Aug; 12(8):1246-52. PubMed ID: 9258755
[TBL] [Abstract][Full Text] [Related]
13. The cellular and clinical parameters of anabolic therapy for osteoporosis.
Rosen CJ
Crit Rev Eukaryot Gene Expr; 2003; 13(1):25-38. PubMed ID: 12839095
[TBL] [Abstract][Full Text] [Related]
14. New anabolic therapies in osteoporosis.
Rubin MR; Bilezikian JP
Endocrinol Metab Clin North Am; 2003 Mar; 32(1):285-307. PubMed ID: 12699304
[TBL] [Abstract][Full Text] [Related]
15. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
16. Clinical review 123: Anabolic therapy for osteoporosis.
Rosen CJ; Bilezikian JP
J Clin Endocrinol Metab; 2001 Mar; 86(3):957-64. PubMed ID: 11238469
[TBL] [Abstract][Full Text] [Related]
17. [Effect of PTH on bone structural properties].
Ito M
Clin Calcium; 2012 Mar; 22(3):335-41. PubMed ID: 22370300
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone and its analogues--molecular mechanisms of action and efficacy in osteoporosis therapy.
Misiorowski W
Endokrynol Pol; 2011; 62(1):73-8. PubMed ID: 21365583
[TBL] [Abstract][Full Text] [Related]
19. Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling.
Siddiqui JA; Le Henaff C; Johnson J; He Z; Rifkin DB; Partridge NC
Bone; 2021 Feb; 143():115762. PubMed ID: 33212319
[TBL] [Abstract][Full Text] [Related]
20. ZT-031, a cyclized analog of parathyroid hormone(1-31) for the potential treatment of osteoporosis.
Nemeth EF
IDrugs; 2008 Nov; 11(11):827-40. PubMed ID: 18988128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
